Canara HSBC Life IPO Subscribed over 0.27x on Day 2

Canara HSBC Life's subscription started on October 10, 2025, and the IPO will close on October 14, 2025, as per the schedule. The price band is set at ₹100 to ₹106 per share with a face value of ₹10.

Table of Contents

Canara HSBC Life IPO Subscription Status 

Canara HSBC Life IPO subscribed over 0.27x on its second day till 5.00 PM on October 13, 2025.  

  • Canara HSBC Life IPO subscription QIB investors’ portion is 0.32 times, while NII subscribed 0.14 times, and RII investors subscribed 0.28 times. 
  • The company has received bids for 4,46,72,600 shares against 16,67,15,000 shares on offer on the second day of subscription. 
  • Canara HSBC Life IPO subscribed over 0.27x on its day 2.   
  • Canara HSBC Life IPO subscribed over 0.09x on its day 1.   

About Canara HSBC Life Company 

Founded in 2007, Canara HSBC Life is one of the growing private life insurance companies in India, promoted by Canara Bank and HSBC Insurance (Asia-Pacific) Holdings Limited. The Canara HSBC Life is involved in providing a wide range of life insurance products for individuals and groups, including savings, term plans, retirement solutions, group protection plans, endowment plans, and the Pradhan Mantri Jeevan Jyoti Bima Yojana (PMJJBY). 

As of now, the company’s portfolio consists of 20 individual products, 7 group products, and 2 rider options, along with PMJJBY policies. What makes this company unique is its product offers protection, guaranteed income, and market-linked growth, with flexible payouts, investment options, and customization features. The main reason behind strong business growth through the bancassurance partnerships with its promoters. Multi-channel distribution network with PAN-India presence is one of the major strengths of the company. 

Canara HSBC Life  IPO GMP: 

Canara HSBC Life  IPO GMP was ₹2 as of Monday, 13 October 2025. That indicates the IPO is trading at ₹108 with a ₹2 premium in the grey market against the issue price of ₹106. 

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.